A more recent version of this article appeared on September 14, 2001

This Article Full Text Full Text (PDF) All Versions of this Article: 89/6/503    most recent hh1801.096265v1 Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yang, Z.-H. Articles by Hiwada, K. Search for Related Content PubMed Articles by Yang, Z.-H. Articles by Hiwada, K. Related Collections Remodeling Gene expression Growth factors/cytokines Smooth muscle proliferation and differentiation

© 2001 American Heart Association, Inc.

Article

Targeted Overexpression of CCAAT/Enhancer-Binding Protein- Evokes Enhanced Gene Transcription of Platelet-Derived Growth Factor -Receptor in Vascular Smooth Muscle Cells

Zhao-Hui Yang, Yutaka Kitami, Yasunori Takata, Takafumi Okura Kunio Hiwada

From The Second Department of Internal Medicine, Ehime University School of Medicine, Ehime, Japan.

Correspondence to Yutaka Kitami, MD, The Second Department of Internal Medicine, Ehime University School of Medicine, Ehime 791-0295, Japan. E-mail kitamiyk{at}m.ehime-u.ac.jp

Abstract — Platelet-derived growth factor (PDGF) is thought to play a significant role in various models of vascular remodeling, particularly in the early process of vascular diseases. Its action is mediated by its specific receptor, the PDGF receptor. The PDGF -receptor (PDGFR) plays an important role in the growth and proliferation of vascular smooth muscle cells (VSMCs), and its gene expression is thought to be regulated by several potential transcriptional nuclear factors. However, the detailed mechanisms of tissue-specific transactivation of the PDGFR gene in VSMCs remain to be clarified. We have previously demonstrated that the rat PDGFR gene contains an enhancer core sequence for CCAAT/enhancer-binding proteins (C/EBPs) in its promoter region, and we have also suggested that C/EBP- is the principal factor involved in the induction of tissue-specific transcriptional activity of the PDGFR gene in VSMCs. To explore the definitive roles of C/EBP- protein on PDGFR gene transcription in VSMCs, we developed C/EBP- transgenic rats by using a chimeric fusion gene of the mouse smooth muscle -actin promoter and an entire coding region of rat C/EBP- cDNA. This report describes the first successful targeted overexpression of C/EBP- capable of inducing PDGFR gene transcription and modifying cell proliferative activity to PDGFs. Targeted overexpression of C/EBP- evokes high levels of PDGFR gene expression, susceptibility to VSMC growth, and proliferation of VSMCs to PDGFs. The results obtained reveal evidence of a new role and new functional significance of C/EBP- on VSMC growth via the PDGFR during the process of vascular remodeling and atherosclerosis.

Key Words: platelet-derived growth factor -receptor • vascular smooth muscle cells • CCAAT/enhancer-binding protein-&dgr • transgenic rats • gene expression

This article has been cited by other articles:

				C. V. Remillard, D. D. Tigno, O. Platoshyn, E. D. Burg, E. E. Brevnova, D. Conger, A. Nicholson, B. K. Rana, R. N. Channick, L. J. Rubin, et al. Function of Kv1.5 channels and genetic variations of KCNA5 in patients with idiopathic pulmonary arterial hypertension Am J Physiol Cell Physiol, May 1, 2007; 292(5): C1837 - C1853. [Abstract] [Full Text] [PDF]

				N. Kaplan-Albuquerque, V. Van Putten, M. C. Weiser-Evans, and R. A. Nemenoff Depletion of Serum Response Factor by RNA Interference Mimics the Mitogenic Effects of Platelet Derived Growth Factor-BB in Vascular Smooth Muscle Cells Circ. Res., September 2, 2005; 97(5): 427 - 433. [Abstract] [Full Text] [PDF]

				N. Kaplan-Albuquerque, Y. E. Bogaert, V. Van Putten, M. C. Weiser-Evans, and R. A. Nemenoff Patterns of Gene Expression Differentially Regulated by Platelet-derived Growth Factor and Hypertrophic Stimuli in Vascular Smooth Muscle Cells: MARKERS FOR PHENOTYPIC MODULATION AND RESPONSE TO INJURY J. Biol. Chem., May 20, 2005; 280(20): 19966 - 19976. [Abstract] [Full Text] [PDF]

				M. Takeji, N. Kawada, T. Moriyama, K. Nagatoya, S. Oseto, S. Akira, M. Hori, E. Imai, and T. Miwa CCAAT/Enhancer-Binding Protein {delta} Contributes to Myofibroblast Transdifferentiation and Renal Disease Progression J. Am. Soc. Nephrol., September 1, 2004; 15(9): 2383 - 2390. [Abstract] [Full Text] [PDF]

				Y.-W. Chen, M. J. Hubal, E. P. Hoffman, P. D. Thompson, and P. M. Clarkson Molecular responses of human muscle to eccentric exercise J Appl Physiol, December 1, 2003; 95(6): 2485 - 2494. [Abstract] [Full Text]

				Y. Takata, Y. Kitami, Z.-H. Yang, M. Nakamura, T. Okura, and K. Hiwada Vascular Inflammation Is Negatively Autoregulated by Interaction Between CCAAT/Enhancer-Binding Protein-{delta} and Peroxisome Proliferator-Activated Receptor-{gamma} Circ. Res., September 6, 2002; 91(5): 427 - 433. [Abstract] [Full Text] [PDF]

				P. A. Watson, C. Vinson, A. Nesterova, and J. E.-B. Reusch Content and Activity of cAMP Response Element-Binding Protein Regulate Platelet-Derived Growth Factor Receptor-{alpha} Content in Vascular Smooth Muscles Endocrinology, August 1, 2002; 143(8): 2922 - 2929. [Abstract] [Full Text] [PDF]

				U. Kelkenberg, A. H. Wagner, J. Sarhaddar, M. Hecker, and H. E. von der Leyen CCAAT/Enhancer-Binding Protein Decoy Oligodeoxynucleotide Inhibition of Macrophage-Rich Vascular Lesion Formation in Hypercholesterolemic Rabbits Arterioscler Thromb Vasc Biol, June 1, 2002; 22(6): 949 - 954. [Abstract] [Full Text] [PDF]